DK343288A - Funktionaliserede polyamin-chelatdannere og rhodiumkomplekser deraf samt fremgangsmaade til fremstilling af rhodiumkomplekserne - Google Patents

Funktionaliserede polyamin-chelatdannere og rhodiumkomplekser deraf samt fremgangsmaade til fremstilling af rhodiumkomplekserne

Info

Publication number
DK343288A
DK343288A DK343288A DK343288A DK343288A DK 343288 A DK343288 A DK 343288A DK 343288 A DK343288 A DK 343288A DK 343288 A DK343288 A DK 343288A DK 343288 A DK343288 A DK 343288A
Authority
DK
Denmark
Prior art keywords
rhodium
procedures
preparation
complexs
complexes
Prior art date
Application number
DK343288A
Other languages
Danish (da)
English (en)
Other versions
DK343288D0 (da
Inventor
Jr William J Kruper
Douglas K Pollock
William A Fordyce
Michael J Fazio
Muthiah N Inbasekaran
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of DK343288D0 publication Critical patent/DK343288D0/da
Publication of DK343288A publication Critical patent/DK343288A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C263/00Preparation of derivatives of isocyanic acid
    • C07C263/10Preparation of derivatives of isocyanic acid by reaction of amines with carbonyl halides, e.g. with phosgene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6887Antibody-chelate conjugates using chelates for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073Rhodium compounds
    • C07F15/008Rhodium compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DK343288A 1987-06-24 1988-06-22 Funktionaliserede polyamin-chelatdannere og rhodiumkomplekser deraf samt fremgangsmaade til fremstilling af rhodiumkomplekserne DK343288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/065,739 US4994560A (en) 1987-06-24 1987-06-24 Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies

Publications (2)

Publication Number Publication Date
DK343288D0 DK343288D0 (da) 1988-06-22
DK343288A true DK343288A (da) 1988-12-25

Family

ID=22064774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK343288A DK343288A (da) 1987-06-24 1988-06-22 Funktionaliserede polyamin-chelatdannere og rhodiumkomplekser deraf samt fremgangsmaade til fremstilling af rhodiumkomplekserne

Country Status (19)

Country Link
US (2) US4994560A (ko)
EP (1) EP0296522B1 (ko)
JP (1) JP2728437B2 (ko)
KR (1) KR970011005B1 (ko)
CN (1) CN1022839C (ko)
AT (1) ATE143364T1 (ko)
CA (1) CA1341349C (ko)
DE (1) DE3855564T2 (ko)
DK (1) DK343288A (ko)
ES (1) ES2091746T3 (ko)
FI (1) FI101378B1 (ko)
GR (1) GR3021537T3 (ko)
HK (1) HK1006168A1 (ko)
HU (1) HU201333B (ko)
IL (1) IL86835A (ko)
NO (1) NO178928C (ko)
NZ (1) NZ225070A (ko)
PT (1) PT87802B (ko)
ZA (1) ZA884545B (ko)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132409A (en) * 1987-01-12 1992-07-21 Bracco Industria Chimica S.P.A. Macrocyclic chelating agents and chelates thereof
US5006643A (en) * 1987-06-24 1991-04-09 The Dow Chemical Company Process for preparing isothiocyanato functionalized metal complexes
EP0353450B1 (en) * 1988-06-24 1995-03-29 The Dow Chemical Company Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
ZA894792B (en) * 1988-06-24 1991-04-24 Dow Chemical Co Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
US5756065A (en) * 1988-06-24 1998-05-26 The Dow Chemical Company Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
WO1990007261A2 (en) * 1988-12-22 1990-07-12 The Dow Chemical Company Process for preparing mono-n-alkylated polyazamacrocycles
JP2930708B2 (ja) * 1988-12-23 1999-08-03 ザ ダウ ケミカル カンパニー イソチオシアナト官能化金属錯体の製造方法
US5292868A (en) * 1989-05-26 1994-03-08 Akzo N.V. Chelating agents for attaching metal ions to proteins
US5808003A (en) * 1989-05-26 1998-09-15 Perimmune Holdings, Inc. Polyaminocarboxylate chelators
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
EP0511275A1 (en) * 1990-01-19 1992-11-04 Nycomed Imaging As Chelating compounds
AU7587091A (en) * 1990-03-26 1991-10-21 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A fonctionalized complexand
US5283293A (en) * 1990-12-14 1994-02-01 Corvas, Inc. Reagents for automated synthesis of peptide analogs
GB9105489D0 (en) * 1991-03-15 1991-05-01 Johnson Matthey Plc Improvements in chemical compounds
US5410043A (en) * 1991-12-06 1995-04-25 Schering Aktiengesellschaft Process for the production of mono-N-substituted tetraaza macrocycles
DE4140779A1 (de) * 1991-12-06 1993-06-09 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Verfahren zur herstellung von mono-n-substituierten tetraazamakrocyclen
GB9126677D0 (en) * 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
WO1993020852A2 (en) * 1992-04-13 1993-10-28 The Dow Chemical Company Macrocyclic chelating agents, chelates and conjugates thereof
US5310535A (en) * 1992-04-24 1994-05-10 The Dow Chemical Company Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
EP0588229A3 (en) * 1992-09-12 1994-06-15 Hoechst Ag Macrocyclic chelating agents for the preparation of technetium or rhenium complexes
WO1995026206A1 (en) * 1994-03-28 1995-10-05 The Regents Of The University Of California Method for preparing radionuclide-labeled chelating agent-ligand complexes
CA2188530A1 (en) * 1994-04-22 1995-11-02 John Charles Alexander Diagnostic image analysis with metal complexes
WO1995029925A1 (en) * 1994-04-29 1995-11-09 The Curators Of The University Of Missouri Thioether compounds for use in preparing bifunctional chelating agents for therapeutic radiopharmaceuticals
US7597886B2 (en) * 1994-11-07 2009-10-06 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
US7820798B2 (en) * 1994-11-07 2010-10-26 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
US5663161A (en) * 1995-02-17 1997-09-02 The Research Foundation Of State University Of New York Anti-viral triaza compounds
US5719033A (en) * 1995-06-28 1998-02-17 Motorola, Inc. Thin film transistor bio/chemical sensor
DE69617685T2 (de) * 1995-06-28 2002-06-13 Nen Life Science Products, Inc.(N.D.Ges.Des Staates Delaware) Zusammensetzung und verfahren zur stabilisierung von radiomarkierten organischen verbindungen
BR9610241A (pt) 1995-08-17 1999-06-29 Monsanto Co Processos para análise de imagem de diagnóstico utilizando bioconjgados de complexos de metal de ligandos macrocíclicos contendo nitrogênio
US5871436A (en) * 1996-07-19 1999-02-16 Advanced Cardiovascular Systems, Inc. Radiation therapy method and device
US5782740A (en) * 1996-08-29 1998-07-21 Advanced Cardiovascular Systems, Inc. Radiation dose delivery catheter with reinforcing mandrel
US6143849A (en) * 1996-11-27 2000-11-07 The United States Of America As Represented By The Secretary Of The Navy Synthesis of acrylate and alkyl acrylate monomers and polymers of chelators
US6776792B1 (en) * 1997-04-24 2004-08-17 Advanced Cardiovascular Systems Inc. Coated endovascular stent
US6210312B1 (en) 1997-05-20 2001-04-03 Advanced Cardiovascular Systems, Inc. Catheter and guide wire assembly for delivery of a radiation source
US6159140A (en) * 1998-02-17 2000-12-12 Advanced Cardiovascular Systems Radiation shielded catheter for delivering a radioactive source and method of use
US6159139A (en) * 1998-02-17 2000-12-12 Advanced Cardiovascular Systems Inc. Radiation delivery catheter with a spring wire centering mechanism
US6224535B1 (en) 1998-02-17 2001-05-01 Advanced Cardiovascular Systems, Inc. Radiation centering catheters
US6235363B1 (en) 1998-05-06 2001-05-22 Avery Dennison Corporation Composite construction containing barrier layer
AU3501700A (en) 1999-02-26 2000-09-14 Human Genome Sciences, Inc. Human endokine alpha and methods of use
US6790228B2 (en) * 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US6605031B1 (en) 1999-09-22 2003-08-12 Advanced Cardiovascular Systems, Inc. Stepped centering balloon for optimal radiation delivery
US6582417B1 (en) 1999-09-22 2003-06-24 Advanced Cardiovascular Systems, Inc. Methods and apparatuses for radiation treatment
US7994449B2 (en) 2000-02-16 2011-08-09 Advanced Cardiovascular Systems, Inc. Square-wave laser bonding
US6540734B1 (en) 2000-02-16 2003-04-01 Advanced Cardiovascular Systems, Inc. Multi-lumen extrusion tubing
EP1278544A4 (en) 2000-04-12 2004-08-18 Human Genome Sciences Inc ALBUMIN FUSION PROTEINS
WO2001096528A2 (en) 2000-06-15 2001-12-20 Human Genome Sciences, Inc. Human tumor necrosis factor delta and epsilon
WO2002002641A1 (en) 2000-06-16 2002-01-10 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to blys
US6783793B1 (en) * 2000-10-26 2004-08-31 Advanced Cardiovascular Systems, Inc. Selective coating of medical devices
US6764505B1 (en) * 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
MXPA03010747A (es) 2001-05-25 2004-03-02 Human Genome Sciences Inc Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral.
US7862495B2 (en) * 2001-05-31 2011-01-04 Advanced Cardiovascular Systems, Inc. Radiation or drug delivery source with activity gradient to minimize edge effects
US6565659B1 (en) * 2001-06-28 2003-05-20 Advanced Cardiovascular Systems, Inc. Stent mounting assembly and a method of using the same to coat a stent
US6656216B1 (en) * 2001-06-29 2003-12-02 Advanced Cardiovascular Systems, Inc. Composite stent with regioselective material
SI1411918T1 (sl) 2001-07-31 2012-04-30 Genzyme Global S A R L Postopki za mobilizacijo progenitorskih/matičnih celic
US20080194481A1 (en) 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
EP2277910A1 (en) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin fusion proteins
EP1497445A2 (en) * 2002-04-01 2005-01-19 Human Genome Sciences, Inc. Antibodies that specifically bind to gmad
EP1499352A4 (en) 2002-04-12 2006-10-11 Medimmune Inc ANTI-INTERLEUKIN-9 RECOMBINANT ANTIBODIES
CN100418981C (zh) * 2002-06-10 2008-09-17 瓦西尼斯公司 在乳腺癌和膀胱癌中差异表达的基因及编码多肽
US7169178B1 (en) * 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
AU2003302254A1 (en) * 2002-12-16 2004-07-22 Avery Dennison Corporation Analyte detecting article and method
US7198675B2 (en) * 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
GB0416062D0 (en) 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
CN1913921B (zh) * 2003-12-04 2012-02-22 瓦西尼斯公司 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法
US7563324B1 (en) 2003-12-29 2009-07-21 Advanced Cardiovascular Systems Inc. System and method for coating an implantable medical device
PL1729795T3 (pl) 2004-02-09 2016-08-31 Human Genome Sciences Inc Białka fuzyjne albuminy
EP1786463A4 (en) * 2004-03-26 2009-05-20 Human Genome Sciences Inc ANTIBODY AGAINST NOGO RECEPTOR
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US20050288481A1 (en) * 2004-04-30 2005-12-29 Desnoyer Jessica R Design of poly(ester amides) for the control of agent-release from polymeric compositions
US7632307B2 (en) 2004-12-16 2009-12-15 Advanced Cardiovascular Systems, Inc. Abluminal, multilayer coating constructs for drug-delivery stents
US20060216431A1 (en) * 2005-03-28 2006-09-28 Kerrigan Cameron K Electrostatic abluminal coating of a stent crimped on a balloon catheter
CN101198624B (zh) 2005-05-06 2012-10-10 津莫吉尼蒂克斯公司 Il-31单克隆抗体及使用方法
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US20070148251A1 (en) * 2005-12-22 2007-06-28 Hossainy Syed F A Nanoparticle releasing medical devices
NZ571068A (en) 2006-03-21 2012-06-29 Genentech Inc An antibody that can bind human alpha5beta1
US8069814B2 (en) 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
US8603530B2 (en) * 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8048448B2 (en) * 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
CN101505793A (zh) * 2006-06-22 2009-08-12 瓦西尼斯公司 用于治疗癌症的抗c35抗体
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
CA2660175C (en) 2006-09-01 2015-05-12 Zymogenetics, Inc. Variable region sequences of il-31 monoclonal antibodies and methods of use
WO2008105473A1 (ja) * 2007-02-28 2008-09-04 National University Corporation Chiba University 抗悪性腫瘍薬
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
EA020457B1 (ru) 2007-12-07 2014-11-28 Займоджинетикс, Инк. Молекулы гуманизированных антител, специфичных к il-31
AU2008341050B2 (en) 2007-12-26 2013-10-24 Vaccinex, Inc. Anti-C35 antibody combination therapies and methods
EP3913367A1 (en) 2008-12-30 2021-11-24 Children's Medical Center Corporation Method of predicting acute appendicitis
PE20120770A1 (es) 2009-03-25 2012-07-10 Genentech Inc ANTICUERPOS ANTI alfa5ß1 CON ACTIVIDAD SOBRE GLIOBLASTOMAS
EP2464622B1 (en) 2009-10-08 2014-07-23 ANGUS Chemical Company Low-voc polyamines
EP2569335B1 (en) 2010-05-14 2018-08-22 Orega Biotech Methods of treating and/or preventing cell proliferation disorders with il-17 antagonists
GB201008584D0 (en) * 2010-05-22 2010-07-07 Univ Warwick Novel iridium anti-cancer compounds
US10384078B2 (en) * 2013-10-15 2019-08-20 Ip Liberty Vision Corporation Polymeric radiation-sources
JP6691872B2 (ja) 2014-05-30 2020-05-13 ヘンリクス バイオテック カンパニー リミテッド 抗上皮増殖因子受容体(egfr)抗体
EP3029032A1 (en) * 2014-12-05 2016-06-08 Centre National de la Recherche Scientifique (CNRS) Bifunctional do2pa derivatives, chelates with metallic cations and use thereof
SG10201913158PA (en) 2015-04-03 2020-02-27 Eureka Therapeutics Inc Constructs targeting afp peptide/mhc complexes and uses thereof
JP6952605B2 (ja) 2015-04-24 2021-10-20 ジェネンテック, インコーポレイテッド 多特異性抗原結合タンパク質
EP4339615A3 (en) 2016-09-16 2024-05-22 Shanghai Henlius Biotech, Inc. Anti-pd-1 antibodies
EP3568468A4 (en) 2017-01-12 2020-12-30 Eureka Therapeutics, Inc. RECOMBINATION PRODUCTS TARGETING PEPTIDE HISTONE H3 / MHC COMPLEXES AND THEIR USES
SG11201909728XA (en) 2017-04-26 2019-11-28 Eureka Therapeutics Inc Constructs specifically recognizing glypican 3 and uses thereof
US11485782B2 (en) 2018-03-14 2022-11-01 Beijing Xuanyi Pharmasciences Co., Ltd. Anti-claudin 18.2 antibodies
SG11202012342WA (en) 2018-06-18 2021-01-28 Eureka Therapeutics Inc Constructs targeting prostate-specific membrane antigen (psma) and uses thereof
CN112300279A (zh) 2019-07-26 2021-02-02 上海复宏汉霖生物技术股份有限公司 针对抗cd73抗体和变体的方法和组合物
CN110818795B (zh) 2020-01-10 2020-04-24 上海复宏汉霖生物技术股份有限公司 抗tigit抗体和使用方法
WO2023109900A1 (en) 2021-12-17 2023-06-22 Shanghai Henlius Biotech, Inc. Anti-ox40 antibodies, multispecific antibodies and methods of use
CN118574849A (zh) 2021-12-17 2024-08-30 上海复宏汉霖生物技术股份有限公司 抗ox40抗体和使用方法
WO2023179740A1 (en) 2022-03-25 2023-09-28 Shanghai Henlius Biotech , Inc. Anti-msln antibodies and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803528C2 (de) * 1977-03-09 1984-10-18 Tabushi, Iwao, Kyoto Schwermetallionen-Adsorbens und dessen Verwendung zum Adsorbieren von Schwermetallionen
US4622420A (en) * 1980-03-18 1986-11-11 The Regents Of The University Of California Chelating agents and method
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4479930A (en) * 1982-07-26 1984-10-30 Trustees Of The University Of Massachusetts Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product
US4615876A (en) * 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4678667A (en) * 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
GB8603537D0 (en) * 1986-02-13 1986-03-19 Parker D Conjugate compound
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
US5006643A (en) * 1987-06-24 1991-04-09 The Dow Chemical Company Process for preparing isothiocyanato functionalized metal complexes

Also Published As

Publication number Publication date
IL86835A0 (en) 1988-11-30
FI883046A0 (fi) 1988-06-23
ES2091746T3 (es) 1996-11-16
IL86835A (en) 1994-01-25
PT87802A (pt) 1989-05-31
ATE143364T1 (de) 1996-10-15
NO178928B (no) 1996-03-25
NZ225070A (en) 1992-10-28
CN1022839C (zh) 1993-11-24
ZA884545B (en) 1990-02-28
KR970011005B1 (ko) 1997-07-05
US5284644A (en) 1994-02-08
US4994560A (en) 1991-02-19
HUT48636A (en) 1989-06-28
HU201333B (en) 1990-10-28
DE3855564D1 (de) 1996-10-31
JPS6426586A (en) 1989-01-27
AU1833288A (en) 1989-01-05
EP0296522A3 (en) 1990-07-04
NO882784D0 (no) 1988-06-23
PT87802B (pt) 1992-10-30
CN1030588A (zh) 1989-01-25
DE3855564T2 (de) 1997-02-13
FI101378B (fi) 1998-06-15
DK343288D0 (da) 1988-06-22
GR3021537T3 (en) 1997-02-28
JP2728437B2 (ja) 1998-03-18
HK1006168A1 (en) 1999-02-12
NO882784L (no) 1988-12-27
EP0296522B1 (en) 1996-09-25
FI883046A (fi) 1988-12-25
EP0296522A2 (en) 1988-12-28
NO178928C (no) 1996-07-03
FI101378B1 (fi) 1998-06-15
KR890000408A (ko) 1989-03-14
CA1341349C (en) 2002-03-19
AU614973B2 (en) 1991-09-19

Similar Documents

Publication Publication Date Title
DK343288A (da) Funktionaliserede polyamin-chelatdannere og rhodiumkomplekser deraf samt fremgangsmaade til fremstilling af rhodiumkomplekserne
NO791596L (no) Hydrofile, alkoholuopploeselige polyamidmembraner og fremgangsmaate for fremstilling derav
KR900701765A (ko) 마이크로사이클릭 이작용성 킬레이트제, 이들의 착화합물 및 이들의 항체 결합물
DE3851892D1 (de) Ultraschalldiagnosegerät.
IT1068324B (it) Dializzatore specialmente per la emodialisi e procedimento per la sua fabbricazione
NO884342L (no) Inhaleringsanordning.
DE3884689D1 (de) Vorrichtung zum Durchströmen von Dampf.
NO881265D0 (no) Innretning for kombinasjonsspill.
DE3850660D1 (de) Ultraschall-diagnosevorrichtung.
IT1067959B (it) Laminato tessile,nonche' procedimento e dispositivo per la sua fabbricazione
DE3872087D1 (de) Sauermilch.
DE3854303D1 (de) Ultraschall-diagnosegerät.
AT373960B (de) Stulpschiene
NO156604C (no) Modifiserte krysotilasbest-fibre og fremgangsmaate til deres fremstilling.
DE3676153D1 (de) Manschette zum venenvernaehen.
DE58903279D1 (de) Vorrichtung zum herstellen von huettenbims.
DE3877489D1 (de) Gerade gefuehrte antriebsvorrichtung.
IT1208529B (it) Procedimento e dispositivo per la foggiatura di pezzi mediante fucinatura a stampo.
FR2335751A1 (fr) Maillon d'accouplement ou de raccordement
DE3765518D1 (de) Oeffnungsvorrichtung zum oeffnen von gepressten faserballen.
IT8121164V0 (it) Ago per anestesia dentaria intralegamentaria.
ES213910Y (es) Dispositivo unidor de cintas perpendiculares.
NO884472D0 (no) Antistoffer og fremgangsmaater for fremstilling derav.
SE8703950D0 (sv) Armeringsforfarande, metoden z-armering
ATE74782T1 (de) Trainingsvorrichtung.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment